C4 Therapeutics Inc (CCCC)
2.39
+0.00%
C4 Therapeutics Inc (CCCC) is currently trading at $2.39. This represents a gain of 0% from the previous session. With a market capitalization of $0.23B, CCCC is a key component of the Health Care sector. Investors looking to trade CCCC should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade CCCC commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, C4 Therapeutics Inc (CCCC) shows a bullish trend. Analysts are watching the 0.00 level closely.
Fundamentals
Mkt Cap0.23B
P/E Ratio0.0000
Volume5,072
60-Day Technical Chart
Advanced Charting
Need more indicators for CCCC? Use the world's #1 platform.
Open CCCC on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $2
| Metric |
CCCC +0.00% |
RIME +0.00% |
RR +0.00% |
EVH +0.00% |
|---|---|---|---|---|
| Price | $2.39 | $2.18 | $2.57 | $2.56 |
| Mkt Cap | $0.23B | $0.01B | $0.57B | $0.29B |
| - | View → | View → | View → |
Latest Headlines
Investor watch: C4 Therapeutics fireside chats in Boston and Miami
Stock Titan • Feb 23, 2026
Brookline Capital Raises Price Target for C4 Therapeutics (CCCC) to $30 | CCCC Stock News
GuruFocus • Feb 23, 2026
$CCCC stock is up 9% today. Here's what we see in our data.
Quiver Quantitative • Feb 19, 2026
Is C4 Therapeutics (CCCC) One of the Best Biotech Penny Stocks to Buy According to Analysts?
Yahoo Finance • Dec 31, 2025
New oral myeloma drug from C4 Therapeutics enters Phase 2 test
Stock Titan • Feb 23, 2026
● Gemini Agentic AI Analyst Insight for CCCC
Market Education
- Santa Rally: What It Is and How It Affects the Stock Market Dec 10, 2024
- Trump’s New Tariffs Could Push Up Kitchen Renovation Costs Sep 26, 2025
- Bob Shiller got Nobel Prize - Efficient Frontier in Modern Portfolio Theory Jul 18, 2023
External Research